Login
$OSUR
$3.60 -$0.02 (0.55%) Live

$OSUR SEC Filings

Filed On Filing
12 Nov 2026 10-Q/A
09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion

09 Nov 2026 SCHEDULE 13G/A
30 Oct 2026 SCHEDULE 13G/A
01 Oct 2026 Form 4: Boyd Steven Kyle, Director

Received 4,797 shares as a grant or award ($18.6K)

17 Sep 2026 SCHEDULE 13D
09 Sep 2026 Form 4: Kenny John P., Director

Gave up 5,116 shares to cover exercise price or tax ($17.5K)

12 Aug 2026 SCHEDULE 13G
07 Aug 2026 S-8
07 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition

BETHLEHEM, PA, August 5, 2026 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months e...

31 Jul 2026 SCHEDULE 13G/A
30 Jun 2026 Form 4: Boyd Steven Kyle, Director

Received 3,666 shares as a grant or award ($16.2K)

11 Jun 2026 8-K: Other Events

On June 11, 2026, OraSure Technologies, Inc. (the “Company”) announced U.S. Food and Drug Administration (“FDA”) clearance of the Company’s Colli-Pee™•Dx Urine Collection Kit from its subsidiary DNA Genotek Inc., for use with Roche Molec...

05 Jun 2026 Form 4: McMahon Robert W., Director

Received 46,106 shares as a grant or award

05 Jun 2026 Form 4: Gagliano Nancy J, Director

Received 46,106 shares as a grant or award

05 Jun 2026 Form 4: Marmora Lelio, Director

Received 46,106 shares as a grant or award

05 Jun 2026 Form 4: Kenny John P., Director

Received 46,106 shares as a grant or award

05 Jun 2026 Form 4: Bertrand John D., Director

Received 46,106 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support